ESLAのROE（自己資本利益率）は？

Estrella Immunopharma Inc.のROEは251.43%です。

ESLAの配当利回りは？

Estrella Immunopharma Inc.の配当利回りは0.00%です。

ESLAの品質スコア（Quality Score）は？

当社のAIはESLAの総合財務品質を100点中54点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

ESLAは今が買い時ですか？

当社AIのタイミングスコアは100点中0点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

ESLAはどのセクターに属しますか？

Estrella Immunopharma Inc.はHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

ESLA (NASDAQ) 株価分析 | Estrella Immunopharma Inc.

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-05 | FS: 2026-03-31)

ESLA AI Analysis Summary

Our AI summary for ESLA: Estrella Immunopharma Inc. (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of 251.43%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 0/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ESLA

Estrella Immunopharma Inc.

US:NASDAQ STOCK Healthcare >> Biotechnology News 94

USD 0.75

0.04 (6.11%) Day Change

Watchlist Portfolio Compare Chart

-1.69

D/E

251.4%

ROE

-362.3%

ROA

0.00%

Div Yield

ESTRELLA IMMUNOPHARMA INC.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.75 Price 0.04 (6.11%) Day Change	NEWS SCORE: 94

ESLA, ファンダメンタルスコアはnot quite good ( ファンダメンタル = 54) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROAが低い
平均ROEが低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Deepscope 分析

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	94
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.75
PBV / Sector	-5.75 / 44,105.10
Earning Per Share	-0.33

PE / Sector	N/A / 19.37
PEG or PE/Growth / Sector	N/A / 1.06
Average 1M Daily Value	0.04 M GREAT
Average 1W Daily Value	0.03 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 97.23
NPM Average (%) / Sector	N/A / -1,697.84
NPM Change Average (%) / Sector	N/A / 5,097.59
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-362.33 / 185,260.64
ROA Average (%) / Sector	-245.87 / 36,684.64
ROA Change Average (%) / Sector	412.86 / 422,221.42 GREAT
ROE (%) / Sector	251.43 / 243,761.81 GREAT
ROE Average (%) / Sector	-1,192.68 / 48,758.38
ROE Change Average (%) / Sector	1,152.45 / 424,967.86
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.42

登録情報

Analyze Date	2026-08-06 07:59:57
Symbol	ESLA
Name	ESTRELLA IMMUNOPHARMA INC.
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	43.03 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	30.30 / 9,702.21

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 5858 Horton Street, EmeryVille, CA, United States, 94608

Phone: 510 318 9098

Website: https://www.estrellabio.com

Sector: Healthcare >> Biotechnology

Description: Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidate is EB103, which is in Phase I/II clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It offers ARTEMIS, a cell receptor platform to develop and commercialize T-cell therapies targeting CD19 and CD22 for the treatment of hematologic malignancies. It has a collaborative agreement with Eureka and Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California. Estrella Immunopharma, Inc. is a subsidiary of Eureka Therapeutics, Inc.